DOES TOCILIZUMAB INCREASE THE RISK OF INFECTIONS IN PATIENTS UNDERGOING CAR-T THERAPY?

EHA Library, Mona Asslan, 385861

THE CLINICAL SPECTRUM AND PROGNOSTIC FACTORS OF ERDHEIM-CHESTER DISEASE

EHA Library, Jia-Wen Dai, 385864

DETERMINANTS OF HAEMOGLOBIN IN SICKLE CELL DISEASE PATIENTS IN SUB-SAHARAN AFRICA: MAJOR IMPACT OF THE NATIVE COUNTRY AND INDEPENDENT EFFECTS OF INFLAMMATION AND HAEMOLYSIS.

EHA Library, Marica Rossi, 385866

A SINGLE CENTRE PERSPECTIVE ON PREGNANCY OUTCOMES AND SICKLE CELL COMPLICATIONS IN WOMEN ON HYDROXYCARBAMIDE PERI-CONCEPTION.

EHA Library, Maria Gregori, 385867

ONE-YEAR FOLLOW-UP OF A PHASE 2 STUDY OF MITAPIVAT, AN ORAL PYRUVATE KINASE ACTIVATOR, FOR THE TREATMENT OF SICKLE CELL DISEASE

EHA Library, Myrthe van Dijk, 385872

RARE ANAEMIA DISORDERS EUROPEAN EPIDEMIOLOGICAL PLATFORM (RADEEP): DISTRIBUTION OF PATIENTS AFFECTED BY RADS IN EUROPE

EHA Library, Maria Del Mar Mañú Pereira, 385875

PREDICTORS OF VOC RATE DURING LONG-TERM FOLLOW-UP OF PATIENTS WITH HBSS IN A NEWBORN COHORT STUDY

EHA Library, Muriel Ramalli, 385876

POSITRON EMISSION TOMOGRAPHY IMAGING OF VLA-4 AS A NEW BIOMARKER OF VASO-OCCLUSION IN SICKLE CELL DISEASE

EHA Library, Enrico Novelli, 385881

OUTCOMES OF COVID-19 INFECTION IN INDIVIDUALS WITH SICKLE CELL DISEASE OR SICKLE CELL TRAIT: A SYSTEMATIC REVIEW AND META-ANALYSIS

EHA Library, Stéphanie Forté, 385883

ASSESSING THE ROLE OF MICRORNAS IN HYDROXYUREA -MEDIATED HBF INDUCTION IN HAEMOGLOBINOPATHIES PATIENTS

EHA Library, Neha Kargutkar, 385885

L-GLUTAMINE: A NOVEL AND EFFECTIVE THERAPEUTIC TOOL FOR VOC REDUCTION IN SCD

EHA Library, Pablo Bartolucci, 385886

EPELEUTON, A NOVEL SYNTHETIC Ω-3 FATTY ACID, REDUCES ENDOTHELIAL ADHESION OF RED BLOOD CELLS FROM SICKLE CELL DISEASE PATIENTS UNDER PHYSIOLOGICAL FLOW CONDITIONS

EHA Library, Moayed Hamza, 385887

ASSESSING ADHERENCE TO EMERGENCY DEPARTMENT PROTOCOLS FOR SICKLE CELL DISEASE: IMPLICATIONS FOR QUALITY OF CARE

EHA Library, Charlotte van Tuijn, 385888

AVASCULAR NECROSIS IN PATIENTS WITH SICKLE CELL DISEASE: A RETROSPECTIVE ANALYSIS AT A SPECIALIST HAEMOGLOBINOPATHY CENTRE

EHA Library, Niamh Loughran, 385892

THE IMPACT OF ILLNESS PERCEPTION AND STIGMA ON PATIENT-REPORTED OUTCOMES IN SICKLE CELL DISEASE

EHA Library, Savannah Winkler, 385893

MORTALITY AND CLINICAL COMPLICATIONS AMONG PATIENTS WITH SICKLE CELL DISEASE WITH RECURRENT VASO-OCCLUSIVE CRISES IN ITALY

EHA Library, Chuka Udeze, 385895

VOXELOTOR TREATMENT LEADS TO IMPROVED VIABILITY OF SICKLE ERYTHROCYTES

EHA Library, Kadère Konté, 385898

PUBERTAL DEVELOPMENT OF TRANSFUSION DEPENDENT THALASSEMIA PATIENTS AT THE ERA OF ORAL CHELATION WITH DEFERASIROX : RESULTS OF THE FRENCH NATIONAL REGISTRY NATHALY

EHA Library, isabelle Thuret, 385899

MULTIPARAMETRIC CMR AND CARDIAC COMPLICATIONS IN THALASSEMIA INTERMEDIA

EHA Library, Antonella Meloni, 385904

MOTION ABNORMALITIES IN THE LEFT VENTRICLE OF THALASSEMIA INTERMEDIA PATIENTS

EHA Library, Antonella Meloni, 385905

CHRONIC HEPATITIS C VIRUS INFECTION IS ASSOCIATED WITH AN INCREASED RISK OF  CARDIAC COMPLICATIONS IN THALASSEMIA MAJOR

EHA Library, Antonella Meloni, 385907

INDUCTION OF FETAL HEMOGLOBIN BY TARGETED DELETION OF ZINC FINGER DOMAIN WITHIN BCL11A GENE USING CRISPR-CAS9 TECHNOLOGY

EHA Library, Afsar Ali Mian, 385908

NEUROCOGNITIVE FUNCTION AND PSYCHOLOGICAL ASSESSMENT IN TRANSFUSION-DEPENDENT BETA-THALASSEMIA PATIENTS: RELATION TO BRAIN IRON CONTENT

EHA Library, Amira Adly, 385910

EFFECT OF LUSPATERCEPT ON BONE MINERAL DENSITY IN PATIENTS WITH BETA‑THALASSEMIA ENROLLED IN THE PHASE 3 BELIEVE TRIAL

EHA Library, Thomas D. Coates, 385914

IDENTIFICATION OF THE PRO20THR NOVEL VARIANT IN CDIN1 GENE ALLOWED EXPLORING THE BIOLOGICAL PROCESSES IMPAIRED IN CONGENITAL DYSERYTHROPOIETIC ANEMIA TYPE I

EHA Library, Roberta Marra, 385918

SUSTAINED EFFICACY OF SUTIMLIMAB, A COMPLEMENT C1S INHIBITOR, IN PATIENTS WITH COLD AGGLUTININ DISEASE: RESULTS FROM PART B OF THE PHASE 3 CADENZA STUDY

EHA Library, Alexander Röth, 385919

CLINICALLY RELEVANT HEMOGLOBIN RESPONSE IN ADULTS WITH PYRUVATE KINASE DEFICIENCY TREATED WITH MITAPIVAT – A SUB-ANALYSIS OF THE ACTIVATE TRIAL

EHA Library, Hanny Al-Samkari, 385921

MUTATIONS IN THE GAP DOMAIN OF RACGAP1 CAUSE DEVELOPMENTAL AND ERYTHROID DEFECTS IN ZEBRAFISH

EHA Library, Lídia Romero-Cortadellas, 385923

DRUGS ASSOCIATED PORPHYRIA：A PHARMACOVIGILANCE STUDY

EHA Library, qi wang, 385926

LONG-TERM IMPACT OF OLIPUDASE ALFA ENZYME REPLACEMENT THERAPY ON SPLEEN VOLUME AND HEMATOLOGIC MANIFESTATIONS IN CHILDREN AND ADULTS WITH CHRONIC ACID SPHINGOMYELINASE DEFICIENCY

EHA Library, Jesus Villarrubia, 385931

THE DANISH SCREENING PROGRAM FOR HEMOGLOBINOPATHIES: A 16-YEAR REVIEW

EHA Library, Esther Gravholt, 385932

PKM AND PKR EXPRESSION DURING HEMATOPOIESIS AND ERYTHROPOIESIS

EHA Library, Erin Tsai, 385933

CONCOMITANT USE OF SUTIMLIMAB AND COVID-19 VACCINES IN PATIENTS WITH COLD AGGLUTININ DISEASE FROM THE PHASE 3 CARDINAL AND CADENZA STUDIES

EHA Library, Bruno Fattizzo, 385935

COMBINING ALK2 INHIBITION WITH A MODIFIED ACTIVIN RECEPTOR IIA LIGAND TRAP PROVIDED ADDITIVE BENEFITS IN RESOLVING ANEMIA IN A MOUSE MODEL OF ANEMIA OF INFLAMMATION

EHA Library, Emiliano Melgar-Bermudez, 385936

HIGH DOSE IRON IMPAIRS MALIGNANT B-CELL VIABILITY AND IMPROVES IMMUNE ANTITUMOR FUNCTIONS IN CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, Jessica Bordini, 385937

EFFECT OF IRON DEFICIENCY ANEMIA ON PROPRIOCEPTION IN ADULT WOMEN

EHA Library, Ines Mezghani, 385942

TRANSFERRIN NON-CODING VARIANTS CAUSE MRNA DESTABILISATION IN CONGENITAL HYPOTRANSFERRINEMIA

EHA Library, Xenia Ferrer, 385944

GENETIC FACTORS OF IRON OVERLOAD IN HEREDITARY SPHEROCYTOSIS

EHA Library, Lucie Donaty, 385947

CHARACTERIZATION OF THE MUTATION PATTERN OF GENES ASSOCIATED WITH IRON OVERLOAD IN A BRAZILIAN POPULATION

EHA Library, Ana Toreli, 385950

ETIOPATHOGENESIS OF CANCER-RELATED ANEMIA AMONG CHILDREN AND ADOLESCENTS WITH MALIGNANT SOLID TUMORS

EHA Library, Salwa Mostafa Abd El Kader Kader, 385951

HEMATOLOGICAL IMPLICATIONS IN ADOLESCENT GREEK ROMA PREGNANTS

EHA Library, STAMATIA THEODORIDOU, 385952

TOLERABILITY AND SAFETY OF INTRAVENOUS IMMUNOGLOBULINS (5% AND 10%) FOR THE TREATMENT OF PATIENTS WITH SECONDARY IMMUNODEFICIENCIES – FINAL SUBGROUP RESULTS OF A NON-INTERVENTIONAL SAFETY STUDY

EHA Library, Angela Habier, 385953

TECLISTAMAB REDUCES POLYCLONAL IMMUNOGLOBULIN LEVELS AND IMPAIRS VACCINATION RESPONSES IN HEAVILY PRETREATED MM PATIENTS

EHA Library, Kristine Frerichs, 385954

CHRONIC OBSTRUCTIVE PULMONARY DISEASE AND PREVIOUS INFECTIONS HAD IMPACT ON INFECTIOUS COMPLICATIONS IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA TREATED WITH VENETOCLAX: A MULTICENTRE SEIFEM STUDY

EHA Library, Francesco Autore, 385957

MUCORMYCOSIS IN PATIENTS WITH HEMATOLOGIC DISEASES: HOW TO IMPROVE THE PROGNOSIS

EHA Library, Jieru Wang, 385959

CRP IS A CONVENIENT PREDICTIVE MARKER OF THE ANTIPYRETIC EFFECT OF TOCILIZUMAB ON CRS DURING CAR-T CELL THERAPY

EHA Library, Shota Yokoyama, 385862

CELLULAR DYNAMICS IN RESPONDERS AND NON-RESPONDERS AFTER THE TREATMENT OF PATIENTS WITH AGGRESSIVE B-ZELL LYMPHOMAS WITH CHIMERIC ANTIGEN RECEPTOR (CAR) T CELLS

EHA Library, Vladan VUCINIC, 385863

BASELINE CALCIUM WAS ASSOCIATED WITH PROGNOSIS AFTER CAR T-CELL THERAPY

EHA Library, Heng Mei, 385865

COMPARATIVE STUDY OF CYCLOSPORINE VERSUS TACROLIMUS IN ADDITION TO METHOTREXATE AS GRAFT VERSUS HOST DISEASE PROPHYLAXIS IN MATCHED SIBLING ALLOGENEIC STEM CELL TRANSPLANTATION OF SICKLE CELL DISEASE

EHA Library, Mostafa Mohammed Saleh, 385868

THE EFFECT OF HEMATOPOIETIC STEM CELL TRANSPLANTATION ON CEREBRAL PERFUSION AND OXYGEN METABOLISM IN PATIENTS WITH SICKLE CELL DISEASE

EHA Library, Liza Afzali-Hashemi, 385869

PREVALENCE AND RISK FACTORS FOR RETINOPATHY IN SICKLE CELL DISEASE

EHA Library, Kate Gardner, 385870

GENOTYPE GUIDED DISEASE MANAGEMENT IN HBSC SICKLE CELL DISEASE USING PHLEBOTOMY: IMPACT ON SYMPTOMS AND DISEASE PARAMETERS

EHA Library, Anne-Marie Asemissen, 385871

SYSTEMATIC INVESTIGATION OF HYDROXYUREA TREATMENT EFFECT IN PEDIATRIC PATIENTS WITH SICKLE CELL DISEASE

EHA Library, Varsha Bhat, 385873

IN VITRO COMPARISON OF THE EFFECTS OF INCLACUMAB VS CRIZANLIZUMAB ON REDUCING ENDOTHELIAL ADHESION OF RED BLOOD CELLS IN STANDARDIZED MICROFLUIDIC PLATFORM

EHA Library, Chiara Federici, 385877

EPIDEMIOLOGY AND TREATMENT OF SICKLE CELL DISEASE ASSOCIATED VASO-OCCLUSIVE CRISES IN INPATIENT AND EMERGENCY CARE SETTINGS:  A SYSTEMATIC LITERATURE REVIEW AND META-ANALYSIS

EHA Library, Ami Patel, 385878

ACCURATE CELL-FREE HEME DOSAGE IN PLASMA CORRELATES WITH ANEMIA, HEMOLYSIS AND SICKLE CELL NEPHROPATHY SEVERITY

EHA Library, Laura Bencheikh, 385879

PATTERNS OF VOXELOTOR USE IN A MULTICENTER, REAL-WORLD STUDY OF PATIENTS WITH SICKLE CELL DISEASE

EHA Library, Biree Andemariam, 385880

THE RELATIONSHIP BETWEEN MEDICATION ADHERENCE, BARRIERS TO MEDICATION ADHERENCE, AND QUALITY OF LIFE IN SICKLE CELL DISEASE

EHA Library, Kathryn King, 385882

AGEING IMPACTS HYDROXYCARBAMIDE DOSING IN PATIENTS WITH SICKLE CELL DISEASE

EHA Library, Isabelle Doss, 385884

REAL-WORLD OUTCOMES AND DIGITALLY MONITORED QUALITY OF LIFE IN CRIZANLIZUMAB-TREATED PATIENTS WITH SICKLE CELL DISEASE.

EHA Library, Kim Summers, 385889

PRACTICE-BASED EVIDENCE: LONG-TERM SAFETY COHORT OF DEFERIPRONE IN PATIENTS WITH SICKLE CELL DISEASE FROM THE US REGISTRY

EHA Library, Sherif Badawy, 385890

INTRAVENOUS FLUID REPLACEMENT THERAPY AND HOSPITAL OUTCOMES FOR VASO-OCCLUSIVE EPISODES IN PATIENTS WITH SICKLE CELL DISEASE

EHA Library, Abraham Haimed, 385891

HYDROXYUREA AND LIMB ULCERS: IS IT WORTH SUSPENDING? RETROSPECTIVE COHORT STUDY OF BRAZILIAN ADULT PATIENTS WITH SICKLE CELL DISEASE

EHA Library, Bruno Benites, 385894

CHARACTERISATION OF QUALITY OF LIFE-LINKED PATIENT-REPORTED OUTCOMES THROUGH A DIGITAL AND CONTINUOUS REMOTE MONITORING ECOSYSTEM IN SICKLE CELL DISEASE.

EHA Library, Kim Summers, 385896

SAFETY PROFILE OF KETOROLAC CONTINUOUS INFUSION IN SICKLE CELL RELATED ACUTE VASO-OCCLUSIVE CRISIS

EHA Library, Valeria Maria Pinto, 385897

MORTALITY AND CLINICAL COMPLICATIONS AMONG PATIENTS WITH TRANSFUSION-DEPENDENT BETA-THALASSEMIA IN ITALY

EHA Library, Chuka Udeze, 385900

ORTHOTOPIC LIVER TRANSPLANT IN SICILIAN HEMOGLOBINOPHATIES PATIENTS

EHA Library, Rita Barone, 385901

CLINICAL DETERMINANTS OF CARDIAC IRON IN REGULARLY TRANSFUSED THALASSEMIA INTERMEDIA PATIENTS

EHA Library, Antonella Meloni, 385902

THROMBOEMBOLIC EVENTS  IN SPLENECTOMISED VERSUS NON-SPLENECTOMISED THALASSEMIA PATIENTS: A META-ANALYSIS OF OBSERVATIONAL STUDIES

EHA Library, Tsampika Vasileia Kalamara, 385903

MITAPIVAT AMELIORATES IN VITRO HUMAN Β THALASSEMIC ERYTHROID MATURATION INDEX AND MODULATES THE EXPRESSION OF THE CYTOPROTECTOR PEROXIREDOXIN-2.

EHA Library, Lucia de Franceschi, 385906

INFLAMMATORY AND SENESCENCE-ASSOCIATED MEDIATORS AFFECT THE PERSISTENCE OF HUMORAL RESPONSE TO COVID-19 MRNA VACCINATION IN TRANSFUSION-DEPENDENT BETA-THALASSEMIC PATIENTS

EHA Library, Chiara Agrati, 385909

HEALTHCARE RESOURCE USE, ECONOMIC BURDEN AND IN-PATIENT MORTALITY IN PATIENTS WITH ALPHA- AND BETA-THALASSEMIA COMPARED TO MATCHED CONTROLS IN THE REAL-WORLD SETTING

EHA Library, Louise Lombard, 385911

CLINICAL COMPLICATIONS AMONG PATIENTS WITH TRANSFUSION-DEPENDENT BETA-THALASSEMIA IN GERMANY

EHA Library, Chuka Udeze, 385912

SAFETY AND EFFICACY OF APOTRANSFERRIN INFUSION IN PATIENTS WITH BETA-THALASSEMIA INTERMEDIA, THE AIM STUDY

EHA Library, Kadère Konté, 385913

THE EMPLOYMENT OF DIRECT ORAL ANTICOAGULANTS IN PATIENTS AFFECTED BY Β-THALASSEMIA: A MULTICENTER ANALYSIS FROM THE EXTENSION-MYOCARDIAL IRON OVERLOAD IN THALASSEMIA NETWORK (E-MIOT)

EHA Library, Simona Raso, 385915

PIEZO1 GAIN-OF-FUNCTION VARIANTS ACCOUNT FOR STRESSED ERYTHROPOIESIS BY ALTERING APOPTOSIS, HYPOXIA CELL RESPONSE, AND GLYCOLYSIS

EHA Library, Barbara Eleni Rosato, 385916

INHIBITION OF COMPLEMENT C1S WITH SUTIMLIMAB IN PATIENTS WITH COLD AGGLUTININ DISEASE (CAD): RESULTS FOLLOWING 9-WEEK OFF-TREATMENT PERIOD (WASHOUT) IN THE PHASE 3 CADENZA STUDY

EHA Library, Alexander Röth, 385917

COINHERITANCE OF PIEZO1 VARIANTS AND MULTI-LOCUS RED BLOOD CELL DEFECTS ACCOUNT FOR THE SYMPTOMATIC PHENOTYPE IN BETA-THALASSEMIA CARRIERS.

EHA Library, Valeria Maria Pinto, 385920

HEMOLYTIC MARKERS, MORTALITY, AND THROMBOEMBOLIC EVENTS IN CAD: RISK ASSESSMENT BY TIME PERIOD SINCE DIAGNOSIS

EHA Library, Quentin A Hill, 385922

THE CLINICAL CHARACTERISTICS AND OVERALL SURVIVAL OF PATIENTS WITH PYRUVATE KINASE DEFICIENCY IN THE UK: A REAL-WORLD STUDY

EHA Library, Sara Higa, 385924

MITAPIVAT EFFICACY IN ADULTS WITH PYRUVATE KINASE DEFICIENCY AND BASELINE HEMOGLOBIN LEVELS >10 G/DL

EHA Library, Rachael Grace, 385925

COMORBIDITIES AND COMPLICATIONS IN ADULTS WITH PYRUVATE KINASE DEFICIENCY ACCORDING TO HEMOGLOBIN STRATA – A DESCRIPTIVE ANALYSIS FROM THE PEAK REGISTRY

EHA Library, Dagmar Pospíŝilová, 385927

CLINICAL AND GENETIC STUDY OF HEREDITARY SPHEROCYTOSIS IN THE SPANISH POPULATION.

EHA Library, Lucia Castilla, 385928

SYSTEMATICALLY REDUCED RED CELL PHOSPHATIDYLSERINE FLIPPASE ACTIVITY IS SUFFICIENT TO INDUCE HEREDITARY HEMOLYTIC ANEMIA

EHA Library, Myrthe van Dijk, 385929

RECOMBINANT ERYTHROPOIETIN IN AUTOIMMUNE HEMOLYTIC ANEMIA WITH INADEQUATE RETICULOCYTOSIS: A SINGLE CENTER PROSPECTIVE STUDY

EHA Library, Giacinto Luca Pedone, 385930

SERUM BIOMARKERS AS PREDICTORS OF RESPONSE TO SUTIMLIMAB IN COLD AGGLUTININ DISEASE (CAD): A POST-HOC ANALYSIS OF PHASE 3 CARDINAL AND CADENZA STUDY DATA

EHA Library, Wilma Barcellini, 385934

ROLE OF HEMOLYSIS AND ITS EFFECTS ON IRON DISTRIBUTION AND IMMUNE CELL POLARIZATION LINKED TO ORGAN INJURY

EHA Library, Christina Mertens, 385938

THE DYNAMIC INTERACTION BETWEEN INFLAMMATION AND THE IRON SENSOR HFE, IN SEVERE MALARIA-INDUCED ANEMIA

EHA Library, Ana Pêgo, 385939

A NEW POTENTIAL AND PREVALENT SIDE EFFECT OF FERRIC CARBOXYMALTOSE: METHEMOGLOBINEMIA. A CASE-CONTROL STUDY.

EHA Library, Muhammet Özbilen, 385940

DIAGNOSTIC ACCURACY OF AN AUTOMATED MAGNETIC RESONANCE IMAGE ANALYSIS SYSTEM FOR THE RAPID EVALUATION OF LIVER IRON CONCENTRATION IN PATIENTS WITH HFE RELATED HEMOCHROMATOSIS.

EHA Library, Tim St Pierre, 385941

A PHASE III, RANDOMISED CONTROLLED SAFETY, EFFICACY AND COST EFFECTIVENESS TRIAL OF INTRAVENOUS IRON ISOMALTOSIDE (I3R) AND FERRIC CARBOXY MALTOSE (FERIUMR) IN SUBJECTS WITH IRON DEFICIENCY ANEMIA

EHA Library, Harikrishnan P, 385943

MITAPIVAT IMPROVES IRON OVERLOAD IN PATIENTS WITH PYRUVATE KINASE DEFICIENCY WHO ARE REGULARLY TRANSFUSED

EHA Library, Eduard J. van Beers, 385945

INITIAL DATA FROM THE BEACON TRIAL: A PHASE 2, RANDOMIZED, OPEN-LABEL TRIAL OF BITOPERTIN IN ERYTHROPOIETIC PROTOPORPHYRIA

EHA Library, Gayle Ross, 385946

WHAT’S DRIVING RDW? IN-VITRO AND IN-SILICO EVIDENCE FOR OXIDATIVE STRESS

EHA Library, Huibert-Jan Joosse, 385948

HEP-25/ERFE RATIO AS A  SUBSTANTIAL PROGNOSTIC MARKER OF ERYTHROPOIESIS IN DIALYSIS-DEPENDENT PATIENTS

EHA Library, Salwa Bakr, 385949

A PREDICTIVE MODEL OF HERPES ZOSTER AFTER ALLOGENEIC HAEMATOPOIETIC STEM CELL TRANSPLANTATION: VZV REACTIVATION AFTER ANTIVIRAL PROPHYLAXIS DISCONTINUATION

EHA Library, Cheng-Jie Feng, 385955

GUIDE PERSONALIZED ANTIBIOTIC STEWARDSHIP FOR PSEUDOMONAS AERUGINOSA BLOODSTREAM INFECTIONS IN AML PATIENTS: BASED ON A MACHINE LEARNING MODEL

EHA Library, xiaomeng feng, 385956

INCIDENCE AND RISK FACTORS OF ACTIVE CARBAPENEM-RESISTANT ENTEROBACTERIACEAE SURVEILLANCE FOR PATIENTS ADMITTED TO HEMATOLOGY DEPARTMENT: A PROPENSITY SCORE MATCHING STUDY.

EHA Library, Ting Yang, 385958

RESISTANCE DIAGNOSTICS TOOL TO COMBAT ANTIBIOTIC RESISTANCE IN HEMATOLOGY WARDS: A MODEL-BASED EVALUATION FROM A LARGE MULTICENTER CASE–CONTROL AND COHORT STUDY

EHA Library, xiaomeng feng, 385960

REDUCTION OF THE PROPHYLACTIC EFFECT OF TIXAGEVIMAB-CILGAVIMAB IN THE OMICRON ERA IN PATIENTS WITH HEMATOLOGICAL MALIGNANCIES AND WITHOUT ANTIBODY RESPONSE FOLLOWING SARS-COV-2 VACCINATION.

EHA Library, Chiara Callegari, 385961